Literature DB >> 11498220

OLIG2 as a specific marker of oligodendroglial tumour cells.

Y Marie, M Sanson, K Mokhtari, P Leuraud, M Kujas, J Y Delattre, J Poirier, B Zalc, K Hoang-Xuan.   

Abstract

OLIG2 is a recently identified transcription factor involved in the specification of cells in the oligodendroglial lineage. We investigated the expression of OLIG2 by in-situ hybridisation in 21 brain tumours: nine grade II and III oligodendrogliomas, three grade II oligoastrocytomas, and nine non-oligodendroglial tumours (four grade IV astrocytomas, two meningiomas, a dysembryoplastic neuroepithelial tumour, and two metastases). OLIG2-positive cells corresponding to neoplastic oligodendrocytes were present in all oligodendrogliomas and oligoastrocytomas. By contrast, OLIG2 expression was not detected in the non-oligodendroglial tumours. Thus, oligodendroglioma probably arise from oligodendrocyte precursor cells. OLIG2 should prove a useful marker for the diagnosis of oligodendroglial tumours.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498220     DOI: 10.1016/S0140-6736(01)05499-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Authors:  Xiaoyi Hu; Pier Paolo Pandolfi; Yi Li; Jason A Koutcher; Marc Rosenblum; Eric C Holland
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.

Authors:  Tao Yang; Qi Zheng; Hui Zhao; Qiu-Xia Zhang; Ming Li; Fang Qi; Kang-Ning Li; Ling Fang; Lei Wang; Yong-Ping Fan
Journal:  Chin J Integr Med       Date:  2016-02-26       Impact factor: 1.978

3.  Oligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorder.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Dorota Maciag; Monica Sathyanesan; Abiye H Iyo; Mohadetheh Moulana; Patrick B Kyle; William L Woolverton; Jose Javier Miguel-Hidalgo; Craig A Stockmeier; Samuel S Newton
Journal:  J Psychiatr Res       Date:  2015-04-20       Impact factor: 4.791

4.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

Review 5.  Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.

Authors:  Dimphna H Meijer; Michael F Kane; Shwetal Mehta; Hongye Liu; Emily Harrington; Christopher M Taylor; Charles D Stiles; David H Rowitch
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

6.  Mesenchymal subtype of glioblastomas with high DNA-PKcs expression is associated with better response to radiotherapy and temozolomide.

Authors:  Baptiste Pinel; Mathilde Duchesne; Julie Godet; Serge Milin; Antoine Berger; Michel Wager; Lucie Karayan-Tapon
Journal:  J Neurooncol       Date:  2017-01-10       Impact factor: 4.130

7.  OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.

Authors:  Ying-Wei Lin; Ramona Deveney; Mary Barbara; Norman N Iscove; Stephen D Nimer; Christopher Slape; Peter D Aplan
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

8.  Clinical, radiological, pathological and prognostic aspects of intraventricular oligodendroglioma: comparison with central neurocytoma.

Authors:  Xiang Xiao; Jun Zhou; Jun Wang; Lei Yang; Chunhong Wang; Yikai Xu; Yuankui Wu
Journal:  J Neurooncol       Date:  2017-09-12       Impact factor: 4.130

Review 9.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

10.  Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.

Authors:  Hideaki Yokoo; Sumihito Nobusawa; Hirohide Takebayashi; Kazuhiro Ikenaka; Koji Isoda; Makoto Kamiya; Atsushi Sasaki; Junko Hirato; Yoichi Nakazato
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.